G/MA/QR/N/EU/5/Add.7  
7 octobre  2021 
(21-7623) Page: 1/5 
Comité de l'accès aux marchés  Original:  anglais  
 
  
NOTIFICATION PRÉSENTÉE CONFORMÉMENT À LA DÉCISION SUR LES  
PROCÉDURES DE NOTIFICATION DES RESTRICTIONS  
QUANTITATIVES (G/L/59/REV.1)  
UNION EUROP ÉENNE 
Addendum  
La communication ci -après, datée du 7 octobre  2021, est distribuée à la demande de la délégation 
de l'Union européenne.  
 
A. Membre notifiant: Union européenne  
B. Date de la notification: 7 octobre  2021 
C. Première notification:  
 Oui 
 Non, dernière notification présentée dans le document (cote du document ): 
G/MA/QR/N/EU/5, G/MA/QR/N/EU/5/Add.1 , G/MA/QR/N/EU/5/Add.2 , 
G/MA/QR/N/EU/5/Add.3, G/MA/QR/N/EU/5/Add.4 , G/MA/QR/N/EU/5/Add. 5 et 
G/MA/QR/N/EU/5/Add. 6 
D. Type de notification:  
 1. Complète (c'est -à-dire notification de toutes les restrictions quantitatives en vigueur ) 
 2. Modifications apportées à une notification faite précédemment dans le document 
G/MA/QR/N/EU/5/Add.3  qui sont de la nature suivante : 
  2.1 Introduction de nouvelles restrictions, telles qu'énumérées dans la section 1 . 
  2.2 Suppression de restrictions, tel qu'indiqué plus bas dans la section G . 
  2.3 Modification d'une restriction notifiée précédemment, tel qu'indiqué dans la 
section 1 . 
 3. Notification inverse de restrictions maintenues par (Membre) :  
E. La notification contient des renseignements pour la période biennale (par exemple 
2012 -2014) : 2020-2022 et concerne des restrictions  en vigueur depuis le 
7 octobre  2021 
F. La présente notification contient les renseignements * ci-après:  
 Section 1:  Liste des restrictions quantitatives actuellement en vigueur . 
 Section 2:  Renvoi à d'autres notifications adressées à l'O MC et contenant des 
renseignements sur des restrictions quantitatives actuellement en vigueur, et 
renseignements additionnels . 
 
* En anglais seulement.  G/MA/QR/N/EU/5/Add.7  
- 2 - 
   L'UE notifie la prorogation  de la prescription relative à l'autorisation des exportations de 
vaccins contre la COVID -19 applica ble aux exportations de vaccins produits par des 
entreprises avec lesquelles l'UE a conclu des accords d'achat anticipé ( figurant dans la 
notification G/MA/QR/N/EU/5/Add. 6) jusqu'au 31 décembre  2021. Sur la base du principe 
de la solidarité internationale,  les exportations vers plus de 100 pays demeurent 
exemptées de la mesure comme, en particulier, les exportations en rapport avec le COVAX 
et dans le contexte d'une action humanitaire d'urgence.  
 
 
 
 
   
  G/MA/QR/N/EU/5/Add.7  
- 3 - 
 
Section 1: List of quantitative restrictions that are currently in force  
 
QR 
No. General 
description of 
the restriction  Type of 
restriction  Tariff line code  (s) 
affected, based on 
HS (2017)  Detailed Product 
Description  WTO Justification  
and Ground for 
Restriction, e.g. 
Other International 
Commitments  National legal basis and 
entry into force  Administration, 
modification of 
previ ously notified 
measures, and other 
comments  
1 2 3 4 5 6 7 
1 Export 
authorisation for 
COVID -19 
vaccines  
 NAL-X ex 3002 20  
ex 2933 99  
ex 2934 99  
ex 3002 90  
ex 3504 00  Vaccines against SARS -
related coronaviruses 
(SARS -CoV species), 
irrespective of their 
packaging, and active 
substances including 
master and working cell 
banks used for the 
manufacture of such 
vaccines  Protection of human life 
or health, inter alia  
 
 Commission Implementing 
Regulation (EU) 
2021/1728 (29 September 
2021)  
extending Implementing 
Regulation (EU) 2021/521 
making specific 
arrangements to the 
mechanism making the 
exportation of certain 
products subject to the 
production of an export 
authorisation;  
Official Journal L  
2021/1728, 29.09.2021  
 
https://eur -
lex.europa.eu/legal -
content/EN/TXT/?uri=CELE
X%3A32021R1728  
 
Application period: from 
1.10.2021 until 31.12.2021  Administration: 
Competent authorities in 
EU Member S tates 
 
Authorisations are 
granted to the extent that 
the volume of exports is 
such that it does not pose 
a threat to the execution 
of Advance Purchase 
Agreements that the 
European Union has 
concluded with vaccine 
manufacturers.  
 
Authorisations are 
granted where exports do 
not pose a threat to the 
security of supply within 
the European Union.  
 
In order to determine 
whether the condition 
above is fulfilled, the 
competent authorities 
shall assess the following 
factors:  
 
       1) Does the destination 
country restrict its own 
exports of vaccines or 
their raw materials, 
either by law or other 
means?  
And   
  G/MA/QR/N/EU/5/Add.7  
- 4 - 
 
QR 
No. General 
description of 
the restriction  Type of 
restriction  Tariff line code  (s) 
affected, based on 
HS (2017)  Detailed Product 
Description  WTO Justification  
and Ground for 
Restriction, e.g. 
Other International 
Commitments  National legal basis and 
entry into force  Administration, 
modification of 
previ ously notified 
measures, and other 
comments  
1 2 3 4 5 6 7 
       2) Are the conditions 
prevailing in the 
destination country 
better or worse than the 
EU's, in particular its 
epidemiological situation, 
its vaccination rate and 
its access to vaccines?  
 
Exemptions include, inter 
alia: 
 
- exports in the context 
of humanitarian aid;  
 
- exports to low and 
middle income countries 
in the COVAX Advance 
Market Commitment 
(AMC) list  
       (https://www.gavi.org/ne
ws/media -room/92 -low-
middle -income -
economies -eligible -
access -covid-19-
vaccines -gavi-covax -amc 
   
  G/MA/QR/N/EU/5/Add.7  
- 5 - 
 
QR 
No. General 
description of 
the restriction  Type of 
restriction  Tariff line code  (s) 
affected, based on 
HS (2017)  Detailed Product 
Description  WTO Justification  
and Ground for 
Restriction, e.g. 
Other International 
Commitments  National legal basis and 
entry into force  Administration, 
modification of 
previ ously notified 
measures, and other 
comments  
1 2 3 4 5 6 7 
       - exports of goods 
purchased and/or 
delivered through 
COVAX, UNICEF and 
PAHO with destination to 
any other COVAX 
participating country;  
 
- EU overseas countries 
and territories;  
 
- Andorra, the Faroe 
Islands, San Marino, 
Vatican City, Büsingen, 
Helgoland , Livigno, Ceuta 
and Melilla;  
 
- Iceland, Liechtenstein 
and Norway . 
 
__________